A simple health questionnaire could be a highly effective tool to pre-screen people for early signs of oesophageal cancer, enabling much earlier diagnosis and treatment, finds a UCL-led study.
Dec 05, 2019
0
1
Pancreatic cancer is the third deadliest form of the disease after lung cancer and colorectal cancer.
Dec 05, 2019
0
2
Prostate cancer is the most common cancer in men in the UK , yet we still don't know all of its causes. The largest ever study to use genetics as a measurement for physical activity to look at its effect on prostate cancer, ...
Dec 05, 2019
0
3
The overall rate of new cancer cases is decreasing in men but increasing in women younger than 80 years, and obesity-related cancers are increasing in young people, according to a study on cancer trends in Canada from 1971 ...
Nov 18, 2019
1
3
Heart attack survivors may have an increased risk of developing cancer compared to people without cardiovascular disease, according to research to be presented at the American Heart Association's Scientific Sessions 2019—November ...
Nov 11, 2019
0
3
The results of a major study across 195 countries, presented today at UEG Week Barcelona 2019, indicate that global death rates for pancreatic cancer and incidence rates for colorectal cancer both increased by 10 percent ...
Oct 22, 2019
0
26
The Cancer Atlas, 3rd edition, a comprehensive global overview of cancer around the globe, concludes that progress in the fight against cancer is not only possible, but achievable. The report was produced by the American ...
Oct 16, 2019
0
2
In an international study, lead by the University of Bergen, the researchers wanted to find out how adult overweight (BMI over 25) and obesity (BMI over 30) increase the risk of different types of cancer.
Oct 11, 2019
0
143
Dear Mayo Clinic: I have brown spots over the top half of my body, which my doctor says are seborrheic keratoses and are harmless. What causes them, and is there a way to prevent more from appearing?
Oct 09, 2019
0
2
With improved treatments, especially the use of anti-cancer immunotherapies, more than two-thirds of all patients diagnosed with diffuse large B-cell lymphoma (DLBCL) will survive. However, after treatment, patients are at ...
Oct 08, 2019
0
2
